Similarly, there was no significant impact on OT-I number or phenotype when mice were treated with blocking antibodies targeting PD-L1 or CD73 – separately or in combination – between day 7 and day 21 of infection (Supplemental Figures 7A–C). The gene discussed is CD274; the disease is infection.